baber/WOPTO huggingface dataset:
Patent EP-1575747-A4 (EP)
Inventor: MANCOSA MICHAEL J
IPC: B03C1/01
Filed: 2003-08-05
Abstract: La présente invention concerne un procédé pour améliorer la susceptibilité magnétique de matières plastiques, afin de faciliter la séparation de ces matières en vue d'un recyclage. Cette invention concerne la matière plastique qui est préparée avec les matériaux d'amélioration, généralement de la magnétite ou des particules ferreuses, dans des quantités situées entre 0,1 et 5 % en poids. La présente invention concerne également un procédé pour produire cette matière plastique et un procédé pour séparer cette matière plastique d'un flux de déchets.
Patent EP-1558334-A4 (EP)
Inventor: OSORIO IVAN
IPC: A61N1/36
Filed: 2003-10-15
Abstract: L'invention concerne un appareil et un procédé de configuration et de contrôle des paramètres thérapeutiques d'un système de dispositif médical dans le traitement de troubles du système nerveux. Dans un mode de réalisation, le système de dispositif médical fonctionne en mode de traitement thérapeutique manuel, dans lequel le système de dispositif médical évalue un ensemble d'informations indiquant une configuration du système. Le système de dispositif médical détermine si l'ensemble d'informations est acceptable. En mode de traitement thérapeutique manuel, le système de dispositif médical applique un traitement thérapeutique à un patient en fonction de l'ensemble d'informations. Si le patient ne tolère pas le traitement thérapeutique, ceci est indiqué par l'utilisateur par l'intermédiaire d'une interface utilisateur. Le système de dispositif médical peut associer l'intolérance du patient à des traitements thérapeutiques de même niveau ou dépassant le niveau de tolérance du patient. Le système de dispositif médical peut, de plus, utiliser ces informations pour empêcher l'administration d'un traitement thérapeutique dépassant le niveau de tolérance du patient au cours d'un mode d'exécution.
Patent EP-1594993-A4 (EP)
Title: Leather laminated decorative panel
Inventor: GAUTHIER SYLVIE
IPC: B44F9/12
Filed: 2004-01-20
Abstract: A heat and pressure consolidated laminate, and method for producing the same, is provided that includes in superimposed relationship a decorative layer consisting essentially of a leather material, an underlay layer, a substrate, and an optional backer layer. The substrate has a first surface and a second surface opposite one another. The underlay layer includes one or more cellulosic sheets impregnated with a thermosetting resin, and is disposed between the decorative layer and the first layer of the substrate. The backer layer includes one or more cellulosic sheets impregnated with a thermosetting resin, and is disposed contiguous with the second surface of the substrate.
Patent EP-1608755-A4 (EP)
Inventor: GAZIT DAN
IPC: C12N15/11
Filed: 2004-03-29
Abstract: La présente invention concerne des procédés, des acides nucléiques et des compositions intervenant dans la régulation de l'activité des SMAD par médiation du TAK-1. En favorisant l'interaction du TAK1 avec les domaines MH2 dans les SMAD, on obtient une régulation négative de l'activité biologique des SMAD. L'activité des SMAP à médiateur BMP subit les effets des TAK1.
Patent EP-1633252-A4 (EP)
Inventor: BESSON GUY M
IPC: A61B8/08
Filed: 2004-06-04
Abstract: L'invention concerne un système intégré d'imagerie médicale radiologique et échographique dans lequel un moyen de détection de rayonnement et un transducteur d'ultrasons peuvent être disposés de manière à effectuer un mouvement de balayage permettant l'acquisition d'images sur des chemins soit identiques soit sensiblement coïncidents. Le moyen de détection de rayonnement et le transducteur à ultrasons peuvent être placés avantageusement du même côté de la partie du corps imagée. Les opérations d'imagerie radiologique et échographique peuvent être séquentielles, en chevauchement partiel ou synchrones. Du fait de la disposition citée, il est possible d'obtenir une précision accrue et de meilleurs rendements médicaux.
Patent EP-1672693-A4 (EP)
Title: Semiconductor device
Inventor: KOBAYASHI HIROYA
IPC: C12P21/02
Filed: 2004-09-24
Abstract: A semiconductor device in which high precision focusing for a photodetecting part and uniformity and stability of high sensitivity at the photodetecting part can be maintained by preventing the thinned part of a semiconductor substrate from bending or cracking. A semiconductor device (1) comprises a semiconductor substrate (10), a wiring board (20), conductive bumps (30), and a resin (32). A CCD (12) and a thinned part (14) are formed on the semiconductor substrate (10). An electrode (16) of the semiconductor substrate (10) is connected with an electrode (22) of the wiring board (20) through the conductive bump (30). The wiring board (20) is subjected to wettability treatment for lowering the wettability to the resin in a region (26a) surrounding a region facing the thinned part (14) and another region (26b) extending outward from the region (26a). The gap between the outer edge part (15) of the thinned part (14) and the wiring board (20) is filled with an insulating resin (32) in order to reinforce the bonding strength of the conductive bump (30).
Patent EP-1680275-A4 (EP)
Inventor: KRISL ERIC M
IPC: B32B9/04
Filed: 2004-11-05
Abstract: Revêtement optique constitué en alternance de couches à indice élevé et a indice faible, comprenant une ou plusieurs couches minces d'inhibition de la croissance cristalline empêchant une telle croissance dans le matériau à indice élevé ou dans le matériau à indice faible. Les couches inhibitrices de croissance cristalline sont constituées d'un matériau différent de celui des couches adjacentes du revêtement Ce matériau et les matériaux à indice élevé ou faible peuvent être identiques ou différents. D'après un aspect de l'invention, il est possible d'augmenter le rapport entre les indices de réfraction des matériaux à indice élevé et à indice faible en utilisant du dioxyde de titane rutile pour le matériau à indice élevé tout en limitant la taille des cristaux du matériaux pour réduire le phénomène de dispersion.
Patent EP-1745450-A4 (EP)
Inventor: GENTRY JASON M
IPC: G08B23/00
Filed: 2005-02-18
Abstract: L'invention concerne un système destiné à l'intégration d'un capteur ou d'une mosaïque de capteurs passifs dans le matelas d'un patient pour la surveillance passive en continu des paramètres physiologiques dans un contexte hospitalier. Pour introduire ce capteur ou cette mosaïque de capteurs dans le matelas, on peut le fixer au couvre-lit qui recouvre le matelas ou le placer à l'intérieur du matelas. Le capteur ou la mosaïque de capteurs peut également être fixé à une couche inférieure située entre l'intérieur du matelas et le couvre-lit.
Patent EP-1730841-A4 (EP)
Title: A scalable non-blocking switching network for programmable logic
Inventor: PANI PETER M
IPC: H03K19/177
Filed: 2005-02-28
Abstract: A scalable non-blocking switching network (SN) having switches (151-160) and intermediate (stages of) conductors that are used to connect a first plurality of conductors to other multiple sets of conductors in a generally unrestricted fashion within respective interconnect resources constraints. The SN (200) can be applied in a wide range of applications, in tandem or hierarchically, to provide a large switch network used in network, routers, and programmable logic circuits. The SN is used to connect a first set of conductors (101-104), through the SN, to multiple sets of conductors in a given logic circuit hierarchy whereby the conductors in each of the multiple sets are equivalent or exchangeable, which in term, by construction, makes the first set of conductors equivalent when used in the next level of circuit hierarchy. The SN is scalable for large sized sets of conductors and can be used hierarchically to enable programmable interconnections among large sized circuits.
Patent EP-1787321-A4 (EP)
Title: Formation of ultra-shallow junctions by gas-cluster ion irridation
Inventor: SKINNER WESLEY J
IPC: H01L21/425
Filed: 2005-03-11
Abstract: Method of forming one or more doped regions (310) in a semiconductor substrate (302) and semiconductor junctions (304) for thereby, using gas cluster ion beams (306).
Patent EP-1738168-A4 (EP)
Inventor: BINDER STEVEN R
IPC: G16B40/10
Filed: 2005-04-20
Abstract: L'invention concerne un ensemble d'anticorps quantifié dans le prélèvement d'un patient et analysé afin de diagnostiquer des maladies systémiques auto-immunes. On utilise dans cette analyse une des diverses techniques de reconnaissance de modèle connues, par exemple l'analyse des k-plus proches voisins, afin de comparer le réseau de données de quantification à des ensembles de données précédemment obtenus de sujets souffrant de maladies systémiques auto-immunes connues, déterminant ainsi la ou les maladies spécifiques dont souffre le patient, ainsi que le degré de fiabilité ou de probabilité de l'exactitude de la détermination. Cette méthode permet d'identifier efficacement une seule maladie, mais également deux ou plusieurs maladies affectant simultanément un patient. Cette méthode est adaptée à un traitement automatique de données, ce qui permet d'éliminer une grande partie des jugements et erreurs humaines auparavant générés dans le diagnostic de ces maladies.
Patent EP-1774049-A4 (EP)
Title: Compositions and methods for determining resistance to inhibitors of virus entry using recombinant virus assays
Inventor: PETROPOULOS CHRISTOS
IPC: C12N7/00
Filed: 2005-06-07
Abstract: The invention provides a method for determining whether a human immunodeficiency virus is resistance to a viral entry inhibitor. The methods are particularly useful for determining resistance to inhibitors that act by a non-competitive mechanism. In certain aspects, the methods comprise determining whether an HIV population is resistant to an HIV entry inhibitor, comprising determining a log-sigmoid inhibition curve comprising data points for entry of the HIV population in the presence of varying concentrations of the HIV entry inhibitor, wherein if the entry of the HIV population cannot be completely inhibited by the HIV entry inhibitor, the HIV population is resistant to the HIV entry inhibitor.
Patent EP-1819830-A4 (EP)
Title: Methods for antibody engineering
Inventor: COUTO FERNANDO JOSE REBELO DO
IPC: C12P21/04
Filed: 2005-11-02
Abstract: The invention provides a method for identifying positions of an antibody that can be modified without significantly reducing the binding activity of the antibody. In many embodiments, the method involves identifying a substitutable position in a parent antibody by comparing its amino acid sequence to the amino acid sequences of a number of related antibodies that each bind to the same antigen as the parent antibody. The amino acid at the substitutable position may be substituted for a different amino acid without significantly affecting the activity of the antibody. The subject methods may be employed to change the amino acid sequence of a CDR without significantly reducing the affinity of the antibody of the antibody, in humanization methods, or in other antibody engineering methods. The invention finds use in a variety of therapeutic, diagnostic and research applications.
Patent EP-1889892-A4 (EP)
Title: Green light emitting phosphor
Inventor: TAKAHARA TAKESHI
IPC: C09K11/61
Filed: 2006-05-26
Abstract: A green-light-emitting phosphor of a high emission brightness when excited by blue light emitted from a blue LED is provided. The green-light-emitting phosphor is represented by a formula M 1-a Si 2 O 2-1/2n X n N 2 :Eu a , wherein M is at least one element of strontium (Sr), barium (Ba) and calcium (Ca); X is at least one element of chlorine (Cl) and bromine (Br);  a  is 0.005  a  0.15 and  n  is 0.02  n  0.2. Substitution of a part of the oxygen (O) in a matrix with at least one halogen element of chlorine (CI) and bromine (Br) gives a green-light-emitting phosphor of higher brightness.
Patent EP-1940385-A4 (EP)
Title: Pharmaceutical composition having a ruthenium oxalato compound and method of using the same
Inventor: CHE CHI-MING
IPC: A61K31/357
Filed: 2006-09-28
Abstract: The present invention relates to a pharmaceutical composition comprising one or more of the following ruthenium oxalato compounds I, II, III and IV as an active ingredient. The pharmaceutical composition can be used for the treatment of viral-infected patients or prophylactic treatment of patients at risk from viral infection.
Patent EP-1931342-A4 (EP)
Inventor: HICKLE RANDALL S
IPC: A61K31/05
Filed: 2006-09-15
Abstract: L'invention concerne une combinaison de médicaments conçue pour être utilisée par des anesthésistes à des fins d'induction et/ou d'administration d'anesthésie générale et de réduction de la réponse de stress à une douleur résultant de stimuli nocifs associés à des procédures chirurgicales . L'invention est appropriée pour être utilisée en anesthésie générale afin de limiter le recours à l'administration d'un relaxant musculaire et permet à des patients de rentrer en voiture chez eux après l'administration de l'anesthésique. L'invention concerne également une combinaison de médicaments composée de propofol (2, 6-diisopropylphenol) et de rémifentanil (N-phenyl-N- (4- piperidinyl) amides), cette combinaison contenant, dans un mode de réalisation préféré, 2 mcg de rémifentanil pour chaque mg of propofol. La combinaison de médicaments de l'invention peut comprendre un conditionnement de deux médicaments en proportions appropriées expédié et vendu dans un flacon ou une seringue à deux compartiments afin de les mélanger immédiatement avant l'utilisation. Dans un autre mode de réalisation, l'invention concerne un médicament unique préparé à l'aide d'agents de conservation appropriés dans une solution aqueuse.
Patent EP-1967305-A4 (EP)
Title: Portable drilling machine
Inventor: OTSUKA KENJI
IPC: G05B19/4062
Filed: 2006-12-13
Abstract: Operability and safety are enhanced by preventing occurrence of overload state again after occurrence of overload. An AC power supply (10) is connected with a motor (12) for rotating a drill through a motor control section (28), a current detecting section (30) and a power switch (36), and connected with a magnet (16) through the power switch (36) and a full-wave rectifier (18). The motor control section (28) rotary-drives the motor according to a signal from a main control section based on the fact that a motor start switch (38) is turned on. The main control section (14) controls a voltage supplied to the motor (12) to lower gradually when the motor (12) enters overload state, and to raise the voltage gradually when overload state is eliminated thus performing normal power supply. Furthermore, the main control section (14) controls the motor control section (28) to stop power supply to the motor (12) when overload state sustains for a predetermined time.
Patent EP-2531598-A4 (EP)
Title: Whsc1 and whsc1l1 for target genes of cancer therapy and diagnosis
Inventor: HAMAMOTO RYUJI
IPC: C12Q1/68
Filed: 2011-02-02
Abstract: Objective methods for diagnosing a predisposition to developing cancer, for example, bladder cancer, breast cancer, cholangiocellular carcinoma, CML, esophageal cancer, HCC, NSCLC, SCLC, osteosarcoma, pancreatic cancer, prostate cancer, renal cell carcinoma, soft tissue tumor and lymphoma, are described herein. In one embodiment, the diagnostic method involves determining an expression level of a WHSC1 or WHSC1L1 gene. The present invention further provides methods of screening for therapeutic agents useful in the treatment of WHSC1 or WHSC1L1 associated disease, such as a cancer, e.g., bladder cancer, breast cancer, cholangiocellular carcinoma, CML, esophageal cancer, HCC, NSCLC, SCLC, osteosarcoma, pancreatic cancer, prostate cancer, renal cell carcinoma, soft tissue tumor and lymphoma. The present invention further provides methods of inhibiting the cell growth and treating or alleviating symptoms of WHSC1 or WHSC1L1 associated diseases. The present invention also features products, including double-stranded molecules and vectors encoding thereof as well as to compositions including them. Also, disclosed are methods of identifying substances for treating or/and preventing lung cancer, using as an index their effect on expression of a WHSC1 or WHSC1L1 gene, or a biological activity of a WHSC1 or WHSC1L1 polypeptide.
Patent EP-2541891-A4 (EP)
Title: Data-generating device, data-generating method, data-generating program, and recording medium
Inventor: TAKAMI SHINYA
IPC: G06T13/80
Filed: 2011-02-24
Abstract: Data is generated which can prevent content displayed on a screen from being accurately replicated. A data-generating device has: an acquiring means that acquires still image data; a still image data generating means that generates a predetermined number of items of still image data in which at least part of pixel values of the acquired still image data are changed, and that makes an average of pixel values of matching display positions between the predetermined number of items of still image data equal to pixel values of matching display positions in the acquired still image data; and a movie data generating means that generates movie data for which each of the generated still image data is displayed at a predetermined frame rate.
Patent EP-2640411-A4 (EP)
Title: Anti-inflammatory compositions
Inventor: KO SAI YING
IPC: A61P29/00
Filed: 2011-11-09
Abstract: Provided herein are methods for the treatment of abnormal inflammation and inflammatory conditions comprising mucosal administration of an effective amount of an interleukin (e.g. IL-2) or a fragment or derivative thereof. Also provided herein are pharmaceutical compositions for mucosal administration for the treatment of abnormal inflammation and inflammatory conditions, the composition comprising said interleukin or fragment or derivative.
Patent EP-0084553-A4 (EP)
Title: Paddle and table ball game and method of playing.
Inventor: SCHLUBACH HENRIK
IPC: A47B3/087
Filed: 1982-07-01
Abstract: A paddle and ball game, having some similarities to "Ping Pong", including a relatively small playing area surface (50) with a rigid divider (14, 103) located at its mid-line serving as a rebounding "net". The table top (17, 101) can be supported at different vertical levels, providing for example three levels of play - a standing level (Fig. 8A); an intermediate, seated, chair level (Figs. 5 & 8B); and a floor level (Fig. 8C) for play while seated on the floor. Hand-held paddles (20, 22) are used to propel a plastic ball (24) from side-to-side by the players.
Patent EP-0222889-A4 (EP)
Title: Cytidine analogs.
Inventor: MOCK GRAHAM A
IPC: C07H19/073
Filed: 1986-05-15
Abstract: An oligonucleotide containing at least one cytidine analog labeled at C4 with a reporter group.
Patent EP-0272256-A4 (EP)
Title: Liquid dispensing apparatus and cartridge.
Inventor: MAURICE DAVID M
IPC: A61F9/00
Filed: 1986-05-30
Abstract: An apparatus (10) for the repetitive dispensing of a predetermined quantity of eyedrops (12) has a cylinder (14) with a restricted opening (18) at a first end (16). A plunger (20) attached to a rod (23) extends into the cylinder (14) from end (22). Biaising member (28) has a ramped cam surface (32) incorporating a pair of steps (46), actuating member (26) has an opposed surface (30) with a projection (44) which rides on ramped cam surface (32) and drops off step (46) when actuating member (26) is rotated. Rotation of the actuating member (26) also advances the actuating member (26) on the threaded member (24). Spring (42) biases surfaces (30 and 32) together. As projection (44) drops over each step (46), plunger (20) is moved incrementally toward end (16) of cylinder (14) to discharge eyedrops (12) through opening (18). A disposable cartridge (50) may be substituted for the cylinder (14).
Patent EP-0438402-A4 (EP)
Title: Paralog affinity chromatography
IPC: G01N33/543
Filed: 1989-03-23
Abstract: A method for affinity chromatography or adsorption of a designated analyte utilizes a paralog as the affinity partner. The immobilized paralog can be used in purification or analysis of the analyte; the paralog can also be used as a substitute for antibody in an immunoassay. The paralog is identified by screening candidate peptide sequences of 4-20 amino acids for specific affinity to the analyte.
Patent EP-0365692-A4 (EP)
IPC: C23C14/56
Filed: 1989-04-20
Abstract: Pellicule en sulfure de polyphénylène à orientation biaxiale et à excellente capacité de déposition, son procédé de production et procédé d'exposition de la pellicule à une déposition sous vide. Une pellicule en sulfure de polyphénylène à orientation biaxiale présente une élongation longitudinale pouvant aller jusqu'à 0,4 % lorsqu'elle est chauffée de 25 à 70°C à une vitesse de 10°C/min. sous une tension de 3 kg par mm2 de la superficie de la section transversale de la pellicule. Par conséquent, lorsque l'on soumet la pellicule à une déposition métallique sous vide dans un appareil de déposition sous vide à enroulement, la pellicule ne se ride guère lorsque la tension longitudinale moyenne appliquée sur la pellicule sur une bobine de refroidissement de l'appareil de déposition sous vide est fixée entre 0,5 et 3 kg par mm2 de la pellicule. On supprime ainsi le phénomène de fixation des rides par la chaleur latente du métal évaporé qui produit des rides sur la pellicule métallisée et provoque une détérioration des propriétés de sa surface (dommages thermiques).
Patent EP-0370090-A4 (EP)
Title: Immunogens and biologically active peptides derived from shared sequences from antigens and anti-idiotypic antibodies or antibodies specific for cellular receptors of the antigens
IPC: C07K19/00
Filed: 1989-04-28
Abstract: A novel method of synthesizing immunogens is disclosed. First a shared sequence between an anti-receptor antibody for an external antigen and antigen itself is determined. The shared sequence is then used to construct peptides which may be used as immunogens. A method of providing agents for binding to cellular receptors is also disclosed. Such receptor binding agents are similarly constructed by determining a shared sequence between anti-receptor antibodies and an external antigen. The resulting products may be used as vaccines or as pharmaceuticals which are either directly active on the target cells, or indirectly active as the result of preventing receptor binding by the subject antigen.
Patent EP-0455724-A4 (EP)
Title: A programmable multi-address pager receiver and method of characterizing same
IPC: G08B3/10
Filed: 1990-01-05
Abstract: The pager receiver including a conventional address decoder, an alert envelope waveform generator, and an alert function mapper is disclosed. The pager is individually and uniquely characterized by programming the alert function mapper to govern the generation of assigned alert annunciation patterns by the waveform generator in response to selected decoded pager addresses and associated functions thereof, and to inhibit alert generation by the waveform generator in response to non-selected decoded pager addresses and associated functions thereof. In one embodiment, the alert signal waveform generator is enabled to respond to the alert function mapper only when the pager address is decoded by the decoder.
Patent EP-0439578-A4 (EP)
Title: Process for the production of trimellitic anhydride with improved color
IPC: C08G63/20
Filed: 1990-08-02
Abstract: A process for the production of trimellitic anhydride with improved color is disclosed. The process comprises heat treating trimellitic anhydride in the presence of oxides of boron or hydrated oxides of boron followed by fractionation. Trimellitic anhydride is used in the manufacture of polyesters and polyamide-imides.